Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 3866-3869, August 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campiglio, M.
Right arrow Articles by Croce, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campiglio, M.
Right arrow Articles by Croce, C. M.
[Cancer Research 59, 3866-3869, August 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

FHIT Loss of Function in Human Primary Breast Cancer Correlates with Advanced Stage of the Disease1

Manuela Campiglio, Yuri Pekarsky, Sylvie Menard, Elda Tagliabue, Silvana Pilotti and Carlo M. Croce2

Kimmel Cancer Institute, Thomas Jefferson University [M. C., Y. P., C. M. C.], Philadelphia, Pennsylvania 19107, and Oncologia Sperimentale E, Istituto Nazionale per lo Studio e la Cura dei Tumori [M. C., S. M., E. T., S. P.], 20133 Milan, Italy

The FHIT gene, encompassing the FRA3B fragile site at chromosome 3p14.2, is a tumor suppressor gene involved in different tumor types. We have assessed 29 human primary breast carcinomas for both the presence of abnormal FHIT transcripts and the Fhit protein levels as compared with the normal breast epithelium of the same patients. In addition, we have also examined a second retrospective series of 156 consecutive breast carcinomas for the expression of the Fhit protein. In nine (31%) cases of the first series, FHIT transcripts were either aberrant or absent as determined by reverse transcription-PCR, and Fhit protein levels in tumors were low or absent as determined immunohistochemically. In 11 other cases (38%), only normal FHIT transcripts were detected by PCR, paralleled by the reduction or absence of Fhit protein. In the remaining nine cases (31%), the presence of the normal FHIT transcript corresponded to protein levels that were similar in tumor and normal breast epithelia. Thus, alterations in FHIT transcripts were detected in 31% of the patients, but reduction or absence of Fhit protein occurred in 69% of the breast carcinoma samples examined. These data suggest that alteration in Fhit expression in breast carcinomas is a frequent event. Analysis of correlation between Fhit expression and pathological, clinical, and biological parameters in these 29 tumors and in a second retrospective series of 156 consecutive primary breast carcinomas indicated that a decrease or an absence of Fhit protein expression is associated with high proliferation and large tumor size.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Bianchi, A. Magnifico, C. Olgiati, N. Zanesi, Y. Pekarsky, E. Tagliabue, C. M. Croce, S. Menard, and M. Campiglio
FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells
PNAS, December 12, 2006; 103(50): 18981 - 18986.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. Bavi, Z. Jehan, V. Atizado, H. Al-Dossari, F. Al-Dayel, A. Tulbah, S. S. Amr, S. S. Sheikh, A. Ezzat, H. El-Solh, et al.
Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1708 - 1718.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. Arun, G. Kilic, C. Yen, B. Foster, D. A. Yardley, R. Gaynor, and R. Ashfaq
Loss of FHIT Expression in Breast Cancer Is Correlated with Poor Prognostic Markers
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1681 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S C L Santos, L R Cavalli, I J Cavalli, R S Lima, B R Haddad, and E M S F Ribeiro
Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil
J. Clin. Pathol., April 1, 2004; 57(4): 374 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Pekarsky, P. N. Garrison, A. Palamarchuk, N. Zanesi, R. I. Aqeilan, K. Huebner, L. D. Barnes, and C. M. Croce
Fhit is a physiological target of the protein kinase Src
PNAS, March 16, 2004; 101(11): 3775 - 3779.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Yang, M. Nakamura, Y. Nakamura, G. Yoshimura, T. Suzuma, T. Umemura, Y. Shimizu, I. Mori, T. Sakurai, and K. Kakudo
Two-Hit Inactivation of FHIT by Loss of Heterozygosity and Hypermethylation in Breast Cancer
Clin. Cancer Res., September 1, 2002; 8(9): 2890 - 2893.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. C. Turner, M. Ottey, D. B. Zimonjic, M. Potoczek, W. W. Hauck, E. Pequignot, C. L. Keck-Waggoner, C. Sevignani, C. M. Aldaz, P. A. McCue, et al.
The Fragile Histidine Triad/Common Chromosome Fragile Site 3B Locus and Repair-deficient Cancers
Cancer Res., July 15, 2002; 62(14): 4054 - 4060.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Roz, M. Gramegna, H. Ishii, C. M. Croce, and G. Sozzi
Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines
PNAS, March 19, 2002; 99(6): 3615 - 3620.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Li, D. H. Moore, Z. H. Meng, B.-M. Ljung, J. W. Gray, and S. H. Dairkee
Increased Risk of Local Recurrence Is Associated with Allelic Loss in Normal Lobules of Breast Cancer Patients
Cancer Res., February 1, 2002; 62(4): 1000 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Kraggerud, P. Aman, R. Holm, A. E. Stenwig, S. D. Fossa, J. M. Nesland, and R. A. Lothe
Alterations of the Fragile Histidine Triad Gene, FHIT, and Its Encoded Products Contribute to Testicular Germ Cell Tumorigenesis
Cancer Res., January 1, 2002; 62(2): 512 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Uematsu, A. Yoshimura, A. Gemma, H. Mochimaru, Y. Hosoya, S. Kunugi, K. Matsuda, M. Seike, F. Kurimoto, K. Takenaka, et al.
Aberrations in the Fragile Histidine Triad (FHIT) Gene in Idiopathic Pulmonary Fibrosis
Cancer Res., December 1, 2001; 61(23): 8527 - 8533.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Yang, G. Yoshimura, T. Suzuma, T. Tamaki, T. Umemura, M. Nakamura, Y. Nakamura, X. Wang, I. Mori, T. Sakurai, et al.
Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Breast Carcinoma
Clin. Cancer Res., December 1, 2001; 7(12): 3869 - 3873.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Maitra, I. I. Wistuba, C. Washington, A. K. Virmani, R. Ashfaq, S. Milchgrub, A. F. Gazdar, and J. D. Minna
High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss
Am. J. Pathol., July 1, 2001; 159(1): 119 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Zöchbauer-Müller, K. M. Fong, A. Maitra, S. Lam, J. Geradts, R. Ashfaq, A. K. Virmani, S. Milchgrub, A. F. Gazdar, and J. D. Minna
5' CpG Island Methylation of the FHIT Gene Is Correlated with Loss of Gene Expression in Lung and Breast Cancer
Cancer Res., May 1, 2001; 61(9): 3581 - 3585.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. I. Lee, J.-C. Soria, K. Hassan, D. Liu, X. Tang, A. El-Naggar, W. K. Hong, and L. Mao
Loss of Fhit Expression Is a Predictor of Poor Outcome in Tongue Cancer
Cancer Res., February 1, 2001; 61(3): 837 - 841.
[Abstract] [Full Text]

Home page
 Vet PatholHome page
G. Borzacchiello, V. Ambrosio, P. Galati, F. Poggiali, A. Venuti, and F. Roperto
The Pagetoid Variant of Urothelial Carcinoma In Situ of Urinary Bladder in a Cow
Vet. Pathol., January 1, 2001; 38(1): 113 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Segawa, T. Sasagawa, K. Saijoh, and M. Inoue
Clinicopathological Significance of Fragile Histidine Triad Transcription Protein Expression in Endometrial Carcinomas
Clin. Cancer Res., June 1, 2000; 6(6): 2341 - 2348.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Mori, K. Mimori, T. Shiraishi, H. Alder, H. Inoue, Y. Tanaka, K. Sugimachi, K. Huebner, and C. M. Croce
Altered Expression of Fhit in Carcinoma and Precarcinomatous Lesions of the Esophagus
Cancer Res., March 1, 2000; 60(5): 1177 - 1182.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
R. Baffa, L. G. Gomella, A. Vecchione, P. Bassi, K. Mimori, J. Sedor, C. M. Calviello, M. Gardiman, C. Minimo, S. E. Strup, et al.
Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary Bladder
Am. J. Pathol., February 1, 2000; 156(2): 419 - 424.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. P. Hao, J. E. Willis, T. G. Pretlow, J. S. Rao, G. T. MacLennan, I. C. Talbot, and T. P. Pretlow
Loss of Fragile Histidine Triad Expression in Colorectal Carcinomas and Premalignant Lesions
Cancer Res., January 1, 2000; 60(1): 18 - 21.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.